A framework for management of hepatitis C in prisons

Area of Science:

• Public Health
• Infectious Diseases
• Hepatology

Background:

• Chronic hepatitis C virus (HCV) infection prevalence in prisons is high, ranging from 12% to 31%.
• Existing community guidelines for HCV care are not consistently applied within correctional facilities.
• Inmates often have limited access to healthcare prior to incarceration.

Purpose of the Study:

• To explore best practices for identification, medical management, and treatment of hepatitis C in prisoners.
• To address the challenges and costs associated with managing HCV within the correctional system.
• To outline a collaborative approach between prison and public health systems for comprehensive HCV care.

Main Methods:

• A meeting of experts in prison health, public health, hepatology, and infectious diseases was convened in January 2003.
• Discussion focused on clinical care, prevention strategies, and necessary collaborations.
• Literature review and expert consensus informed the recommendations.

Main Results:

• There is a lack of agreement on best practices for HCV care among healthcare professionals in prisons.
• High HCV prevalence in prisons presents a significant cost burden to correctional systems.
• Joint provision of targeted HCV testing, standard-of-care management, treatment, and prevention programs is identified as optimal.

Conclusions:

• Collaboration between prison and public health systems is crucial for effective HCV management in inmates.
• Standard-of-care hepatitis C medical management, treatment, and prevention programs should be implemented in prisons.
• Targeted HCV testing and comprehensive care are essential for this vulnerable population.